Nobuko Hijiya, MD, Pediatric Hematology-Oncology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children’s Hospital speaks about A…
David Illson, MD, Ph.D., Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College.@ILSONDavid @sloan_kettering…
Jubilee Brown, MD from the Levine Cancer Institute, and Division of Gynecologic Oncology, Atrium Health speaks about Clinical Activity and…
Sarah E. S. Leary, MD, Associate Professor, Center for Clinical and Translational Research, at the Seattle Children’s Hospital Research Foundation…
Oliver Dorigo, MD, Ph.D., Principal Investigator of the DeCidE1 study and Director of the Gynecologic Oncology Service at Stanford University…
Professor William North, Professor Emeritus of Physiology and Neurobiology at the Geisel School of Medicine at Dartmouth College and was…
Alexander I Spira, MD, Ph.D., FACP from the Virginia Cancer Specialists Research Institute, US Oncology Research speaks about Antitumor Activity…
Rajesh Balkrishnan, BS, MS, Ph.D., Professor Department of Public Health Sciences, University of Virginia speaks about Associations between initiating antihypertensive…
Kathryn Schmitz, Ph.D., MPH, a researcher at the Penn State Cancer Institute who chaired the ACSM’s roundtables – speaks about…
Yanhong Shi, Ph.D., Professor, Department of Developmental and Stem Cell Biology at City of Hope speaks about Targeting PUS7 Suppresses…
Anant Madabhushi, Ph.D., the Donnell Institute Professor of Biomedical Engineering at Case Western Reserve, head of the Center for Computational…
Prof. Jonathan Ledermann from the UCL Cancer Institute, University College London speaks about eUpdate – Newly Diagnosed Epithelial Ovarian Carcinoma…
Dr. Matthew Katz, radiation oncologist in Lowell, MA, speaks with Drs. Jack West & Charu Aggarwal about the evolution of…
Anita Kumar, MD from Memorial Sloan Kettering Cancer Center speaks about Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly…
Jeff M. Michalski, MD, MBA, FASTRO, Professor of Radiation Oncology at Washington University and the Siteman Cancer Center speaks about…
Eric Klein, MD from the Glickman Urological and Kidney Institute at the Cleveland Clinic speaks about Blood Test That Detects…
Denise Riedel Lewis, Ph.D. from the Division of Cancer Control and Population Sciences, National Cancer Institute speaks about the Survival…
Sacha I. Rothschild, MD, Ph.D. from the Department of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel speaks about…
Eyal Talor, Ph.D., Chief Scientific Officer, Cel-Sci speaks about CEL-SCI’S Multikine® Immunotherapy Produces significant 14.1% 5-Year Survival Benefits (62.7% VS…
Amy Turner, Ph.D. from the University of Leeds, The Astbury Centre, Tomlinsonlab@leeds speaks about New treatment approach targets cancer ‘Death…
Monica Swahn, Ph.D. from the International Consortium for Advancing Research on Triple-Negative Breast Cancer, Department of Population Health Sciences, Georgia…
Ugochi Ogu, MD, an assistant professor in the Division of Hematology and Oncology at the University of Tennessee Health Science…
Dr. Larry Shulman of University of Pennsylvania meets with hosts Charu Aggarwal & Jack West to discuss the promise &…
Shahid Gilani, MD from the University Hospital Of North Midlands speaks about Hypofractionated radiotherapy as a definitive treatment for Basal…
Shahid Gilani, MD from the University Hospital Of North Midlands speaks about the Direct Oral Anticoagulants (DOACs) in Cancer-Related Thromboembolism.Link…
Stella K. Kang, MD of the Departments of Radiology, NYU Langone Health speaks about Active Surveillance Strategies for Low-Grade Prostate…
LluÃs Espinosa, MD from IMIM-Hospital del Mar and CIBERONC speaks about Optimising Metastatic Melanoma Therapy By Combining Two Treatments.Link to…
Theresa Deisher, Ph.D. from AVM Biotechnology speaks about FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical Trial.Link to Article:https://www.businesswire.com/news/home/20210713005415/en/FDA-Approves-Accelerated-Dosing-in-Non-Hodgkin%E2%80%99s-LymphomaLeukemia-Clinical-TrialThree of…
Joseph Chao, MD from the City of Hope speaks about the Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite…
Prof. Hemant Kocher, MBBS, MS, MD, FRCS from the Queen Mary University of London speaks about Pentraxin 3 is a…
Yeonjoo Choi, MD from The Catholic University of Korea Incheon St. Mary’s Hospital speaks about T-cell Agonists In Cancer Immunotherapy.Link…
Professor Peter Schmid, FRCP, MD, Ph.D., Professor of Cancer Medicine and Lead of the Centre of Experimental Cancer Medicine at…
Sarbajit Mukherjee, MD, MS, Assistant Professor of Oncology in the Department of Medicine at Roswell Park Comprehensive Cancer Center speaks…
Ian Chau, MD, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust speaks about The CheckMate 648, 649, and 577…
Ellen Kim, MD, Medical Director, Dermatology Clinic, Perelman Center for Advanced Medicine, Professor of Dermatology at the Hospital of the…
Adam Brufsky, M.D., Ph.D. from the Magee-Womens Cancer Program, part of the UPMC Hillman Cancer Center speaks about the ASCO…
Debra Pratt, MD a Breast Surgeon at Cleveland Clinicspeaks about Breast Cancer: Finishing Treatment Soon After Diagnosis Increases Survival.Link to…
Dharmesh Gopalakrishnan, MD, a Hematology-Oncology Fellow at Roswell Park speaks about the ASCO 2021 Abstract – Immune checkpoint inhibitors (ICI)…
Oliver Rosen, MD, CMO of SQZ Biotechnologies speaks about the ASCO 2021 Abstract – Initial results of a first-in-human, dose…
Hosts Jack West and Charu Aggarwal meet with Dr. Vince Miller to discuss the process of deciding to move from…
Josephine Lopes Cardozo, Ph.D. from the Netherlands Cancer Institute speaks about the ASCO 2021 Abstract – Outcome of patients with…
Tony Kurian, MD, Oncology Fellow at H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract…
Prof. Lukas Rob, MD, Ph.D., Head of Obstetrics and Gynecological Oncology at University Hospital Kralovske Vinohrady speaks about the ASCO…
Gianantonio Rosti, MD from the Università di Bologna speaks about OPTIC Primary Analysis: A Dose-Optimization Study of 3 Starting Doses…
Brian Van Tine, MD, Ph.D., associate professor of medical oncology, Washington University School of Medicine speaks about the ASCO 2021…
Professor Gilles Salles from Memorial Sloan Kettering Cancer Center speaks about the ASCO 2021 Abstract – Long-term analyses from L-MIND,…
Howard ‘Jack’ West, MD, Executive Director of Employer Strategy; Associate Clinical Professor, Department of Medical Oncology and; Therapeutics Research at…
Aditya Bardia, MD, MPH, Director of Breast Cancer Research, Mass General Cancer Center, Harvard Medical School speaks about ASCO 2021…
David Illson, MD, Ph.D., Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College speaks…
David Illson, MD, Ph.D., Memorial Sloan Kettering Cancer Center and a professor of medicine at Weill Cornell Medical College.@ILSONDavid @sloan_kettering…
Professor Yves Chabu, Ph.D. from MU College of Arts and Science speaks about Understanding How Cancer Can Relapse.Link to Abstract:https://showme.missouri.edu/2021/understanding-how-cancer-can-relapse/Activating…
Neeraj Agarwal, MD, is a Professor in the Division of Oncology, Department of Medicine, at the Huntsman Cancer Institute at…
Neeraj Agarwal, MD, is a Professor in the Division of Oncology, Department of Medicine, at the Huntsman Cancer Institute at…
Chan Shen, Ph.D., Associate Professor, Department of Surgery Chief, Division of Outcomes, Research and Quality, The Pennsylvania State University speaks…
Dr. Pamela Kunz of Yale Cancer Center speaks with Drs. Charu Aggaral & Jack West about the headwinds of being…
Jose P. Zevallos, MD, MPH, FACS, Associate Professor Otolaryngology-Head and Neck Surgery; Chief Head & Neck Oncologic Surgery at the…
Thomas Brown, MD, Chief Medical Officer, Syapse speaks about ASCO 2021 Abstract – #e21121 – Feasibility of RECIST-based real-world tumor…
Thomas Brown, MD, Chief Medical Officer, Syapse speaks about ASCO 2021 Abstract – #e21047 – Myocarditis as a rare, yet…
Thomas Brown, MD, Chief Medical Officer, Syapse speaks about ASCO 2021 Poster – #9105 – Genomic markers associated with hyperprogression…
Thomas Brown, MD, Chief Medical Officer, Syapse speaks about ASCO 2021 Abstracts – #9105 – Genomic markers associated with hyperprogression…
Philippe Spiess, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract – Clinically…
Anas Alshawa, MD from the University of Arizona speaks about the Effects Of Glutamine For Prevention Of Radiation-induced Esophagitis: A…
Taiga Nishihori, MD from the H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract -…
Sarah E. Hoffe, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about ASCO Abstract – GRECO-2: A…
Peter H. O’Donnell, MD from the University of Chicago speaks about the ASCO 2021 Abstract – Oral Abstract Session: First-Line…
Shilpa Gupta, MD from the Cleveland Clinic speaks about the ASCO 2021 Abstract – SWOG S1216: A phase III randomized…
Kent Hoskins, MD, Co-Leader of the Breast Cancer Research Group and Director of Cancer Genetics at the University of Illinois…
Michal R. Tomaszewski, Ph.D. from H. Lee Moffitt Cancer Center and Research Institute speaks about ASCO 2021 Abstract – Imaging-based…
Julian Andres Marin-Acevedo, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about ASCO 2021 Abstract – Efficacy…
Jonathan Zager, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about ASCO 2021 Abstract – Percutaneous hepatic…
Jonathan Strosberg, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract – Final…
Ana Maria Arance, MD from the Hospital Clinic Barcelona speaks about ASCO 2021 Abstract – Lenvatinib (len) plus pembrolizumab (pembro)…
Paul M. Barr, MD from the University of Rochester Medical Center Department of Neurobiology and Anatomy speaks about the ASCO…
Brian Rini, MD, Professor of Medicine from Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center speaks about Pembrolizumab (pembro) plus axitinib…
Charles E. Geyer, Jr., MD, FACP, Deputy Director of the Houston Methodist Cancer Center, and Study Co-Chair speaks about ASCO…
Brian Durie, MD, part of the iStopMM team and chairman of the International Myeloma Foundation speaks about the study -…
Abdulraheem Yacoub, MD from the University of Kansas Center for Bioinformatics speaks about ASCO 2021 Abstract – A phase 3,…
Abdulraheem Yacoub, MD from the University of Kansas Center for Bioinformatics speaks about ASCO 2021 Abstract – A phase 3,…
Mounzer Agha, MD, is the director of the Mario Lemieux Center for Blood Cancers at UPMC Hillman Cancer Center, and…
Nima Sharifi, MD, director of Cleveland Clinic’s Genitourinary Malignancies Research Center speaks about ASCO 2021 – Abstract – Adrenal-permissive HSD3B1…
Nima Sharifi, MD, director of Cleveland Clinic’s Genitourinary Malignancies Research Center speaks about Cleveland Clinic Researchers Identify New Drug Target…
Giuseppe Curigliano, MD, Ph.D., is Associate Professor of Medical Oncology at the University of Milano and the Head of the…
Ajay Goel, Ph.D., AGAF, chair of the Department of Molecular Diagnostics and Experimental Therapeutics at City of Hope speaks about…
Ajay Goel, Ph.D., AGAF, chair of the Department of Molecular Diagnostics and Experimental Therapeutics at the City of Hope speaks…
Salma K Jabbour, MD from Rutgers Cancer Institute of New Jersey/RWJBarnabas Health speaks about ASCO 2021 Abstract KEYNOTE-799: Phase 2…
Ghassan K. Abou-Alfa, MD, medical oncologist at Memorial Sloan Kettering Cancer Center speaks about the ASCO 2021 Abstract – Pemigatinib…
Pauline Funchain, MD, Medical Oncologist/Cancer Genomics at Cleveland Clinic speaks about the ASCO 2021 Abstract – Final analysis of overall…
Nathan A. Pennell, MD, Ph.D., FASCO, Vice Chair of Clinical Research and Director, Lung Cancer Medical Oncology Program Cleveland Clinic…
Suresh S. Ramalingam, MD, FASCO, Deputy Director, lead of the integration of the research, clinical, and educational components within Winship…
Adam C. Berger, MD, FACS, Chief, Melanoma and Soft Tissue Surgical Oncology, Associate Director for Shared Resources at Rutgers Cancer…
Jorge Cortes, MD, Director of the Georgia Cancer Center discusses the ASCO 2021 Abstract – OPTIC primary analysis: A dose-optimization…
Holly J. Pederson, MD, Director Medical Breast Services, Cleveland Clinic, Associate Professor of Medicine, CCLCM speaks about the ASCO 2021…
Saad Usmani, FACP, MBA, MD from the Department of Hematologic Oncology and Blood Disorders, Atrium Health’s Levine Cancer Institute speaks…
Saad Usmani, FACP, MBA, MD from the Department of Hematologic Oncology and Blood Disorders, Atrium Health’s Levine Cancer Institute speaks…
Pablo Okhuysen, MD, FACP from MD Anderson speaks about the ASCO 2021 Abstract – Impact of Cancer-Related Diarrhea on Changes…
Yelena Y. Janjigian, MD from Memorial Sloan Kettering Cancer Center speaks about ASCO 2021 Abstract FDA Approves Merck’s KEYTRUDA® (pembrolizumab)…
David Ilson, MD from the Memorial Sloan Kettering Cancer Center speaks about the Top 5 ASCO 2021 Abstracts in Gastrointestinal…
Howard ‘Jack’ West, MD, Executive Director of Employer Strategy; Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research at…
Grzegorz S. Nowakowski, MD from the Mayo Clinic speaks about Incyte and MorphoSys Announce First Patient Dosed in Phase 3…
Mingxuan Xu, Ph.D., Research Scientist at MD Anderson speaks about the Implementation of a Novel Web-Based Lesion Selection Tool to…
Murat Ak, MD from UPMC speaks about Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.Link to…
Drs. Charu Aggarwal and Jack West host dynamic GU oncology specialist Dr. Petros Grivas as they discuss how research, mentorship,…
Timothy Ritter, MD, Senior Medical Director, Department of Research and Education GI Alliance Research speaks about U.S. FDA Grants De…
Lenka Kyrych Sadilkova, Ph.D. from SOTIO speaks about the AACR 2021 Poster: SOTIO Demonstrates Strong Potential of SOT102 (ADC Targeting…
Watch our interview with Dr. Howard Soule and Dr. Becky Campbell from the Prostate Cancer Foundation talking about their new…
Richard T Penson, MD, MRCP, Associate Professor, Medicine, Harvard Medical School, and Clinical Director, Medical Gynecologic Oncology, Massachusetts General Hospital…
Dan Sherbenou, MD, Ph.D. from the University of Colorado Medical Campus, Division of Hematology Research, Sherbenou Lab speaks about Older…
Coya Tapia, MD, Ph.D., Surgical and Molecular Pathologist speaks about Decrease in tumor content assessed in biopsies is associated with…
Thomas Brown, MD Syapseâ chief medical officer speaks about Syapse Showcases Real-World Mortality Data in American Society of Clinical Oncologyâs…
Jonathan A. Coleman, MD from Memorial Sloan Kettering Cancer Center speaks about ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial…
Connie Lehman, MD, Ph.D., Diagnostic Radiologist, Chief, Breast Imaging Massachusetts General Hospital speaks about These Doctors Are Using AI to…
Eytan M. Stein, MD, Assistant Attending Physician, and Director, Program for Drug Development in Leukemia, Department of Medicine at Memorial…
Matthew Tate, MD, Ph.D., Associate Professor of Neurological Surgery and Neurology – Ken and Ruth Davee Department Northwestern University Feinberg…
David Berd, MD Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day.Link to…
Scott Loughhead, Ph.D. from SQZ Biotechnologies speaks about AACR 2021Abstract – Peripheral Blood Mononuclear Cells Engineered Via Microfluidic Cell Squeeze®…
Scott Loughhead, Ph.D. from SQZ Biotechnologies speaks about AACR 2021Abstracts – Clinical Applications Abstract Number: 2626 and Technology Abstract Number:…
Dr. Steve Vogl of “Vogl, New York” fame joins hosts Charu Aggarwal and Jack West as they discuss the priorities…
Laura van ’t Veer, Ph.D., Co-Leader, Breast Oncology Program and Director, Applied Genomics at UCSF Helen Diller Family Comprehensive Cancer…
Alexey Danilov, MD, Ph.D., associate director of the Toni Stephenson Lymphoma Center at City of Hope speaks about the AACR…
Dino Mehic, MD from the Medical University of Vienna speaks about Elevated levels of tissue factor pathway inhibitor in patients…
Frederick L. Locke, MD from H. Lee Moffitt Cancer Center and Research Institute speaks about the Society for Immunotherapy of…
Rona Yaeger, MD from Memorial Sloan Kettering Cancer Center speaks about KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.Link to…
In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and…
In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and…
In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and…
In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and…
In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and…
In this video series, presented in March of 2021, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss and…
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year’s…
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year’s…
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year’s…
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year’s…
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year’s…
We continue to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year’s…
For this series of case based panel discussions, Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie…
For this series of case based panel discussions, Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie…
For this years Case Based Panel Discussions – Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with…
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with…
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with…
Julio Chavez, MD from Moffitts Cancer Center & Research Institute speaks about U.S. FDA Approves Yescarta® for Relapsed or Refractory…
Linghua Wang, MD, PhD of MD Anderson speaks about Single-cell Analysis Of Metastatic Gastric Cancer Finds Diverse Tumor Cell Populations…
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with…
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with…
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with…
GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies…
Petros Grivas, MD, Ph.D. Department Of Medicine, Division Of Medical Oncology, University of Washington; Fred Hutchinson Cancer Research Center, and…
Zhen Han, assistant research professor at City of Hope, and Christiane Querfeld, MD, Ph.D., director of the Cutaneous Lymphoma Program…
Xiuning Le, MD, Ph.D., Department of Thoracic-Head and Neck Med Onc, Division of Cancer Medicine MD Anderson speaks about Tepotinib…
Li Du, Ph.D. City of Hope speaks about AACR 2021 Abstract – 1329 – SUMOylation Inhibition Overcomes Dexamethasone Resistance In…
Dawn Marie Stull Medical Science Liaison at Takeda Pharmaceuticals speaks about Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple…
Brigitte Widemann, MD, Deputy Director, Center for Cancer Research, National Cancer Institute speaks about Selumetinib in Children with Inoperable Plexiform…
Robert Seitz, Head of Immune Oncology at Oncocyte speaks about AACR 2021 Abstract: 23 – Validation of a 27-gene immuno-oncology…
Valeria Arango Velez, MD, Founder, Healing Presents speaks about being This Years Astellas Oncology C3 Prize – Innovation Prize Winner.Astellas…
John Baird, MD, Fellow in Hematology/Medical Oncology at Stanford Cancer Center speaks about the Retrospective Study: Immune Reconstitution And Infectious…
Brian Rini, MD Professor of Medicine from Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center speaks about AVEO Oncology Announces U.S.…
Christine Brown, Ph.D. Deputy Director, T Cell Therapeutics Research Laboratory; Professor, Departments of Hematology and Hematopoietic Cell Transplantation and Immuno-Oncology…
Jacob J. Adashek, DO University of South Florida, H. Lee Moffitt Cancer Center and Research Institute discusses the AARC 2021…
Jacob J. Adashek, DO University of South Florida, H. Lee Moffitt Cancer Center and Research Institute discusses AARC 2021 Abstract…
Loretta Erhunmwunsee, MD Assistant Professor, Division of Thoracic Surgery, Department of Surgery; Assistant Professor, Division of Health Equities, Department of…
Dr med Florian Moik from the Medical University of Vienna, Department of Medicine I, Division of Haematology and Haemostaseology, Comprehensive…
Alessandra Larocca, MD, Ph.D. from the University of Torino, AOU S.Giovanni Battista, TORINO, Italy speaks about Dose/Schedule-Adjusted Rd-R vs Continuous…
Iván Márquez Rodas MD, Ph.D. of the Medical Oncology Department, Hospital Gregorio Marañon, Madrid, Spain Speaks about Highlight & Pivotal…
Mandana Emamzadeh, Ph.D., Pharma Analyst at GlobalData speaks about New Standard Of Care In Hepatocellular Carcinoma Shifts The Treatment Paradigm…
Rimas V. Lukas, MD from Northwestern Medicine speaks about Nonmalignant Brain Tumors.Link to Abstract:https://journals.lww.com/continuum/Fulltext/2020/12000/Nonmalignant_Brain_Tumors.6.aspxSUMMARY:REVIEW’S OBJECTIVEMeningioma, pituitary adenoma, craniopharyngioma, and glioneuronal…
Matteo Lambertini, MD, Ph.D. from San Martino Hospital Genoa and the University of Genoa speaks about the Exploratory Analysis: Unexpected…
Hosts Jack West and Charu Aggarwal speak with radiation oncology experts David Palma of the London Health Sciences Centre and…
Paul G. Richardson, MD from Dana-Farber Cancer Institute speaks about FDA Approves Oncopeptides´ PEPAXTO® (melphalan flufenamide) for Patients with Triple-Class…
Satish Shah, MD, Medical Director, Gettysburg Cancer Center speaks about Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial…
Omolola Salako, MBBS, FWACS, Founder and CEO, Oncopadi Technologies speaks about the Astellas Oncology C3 Prize – This Years Grand…
Tito R. Mendoza, Ph.D., MS, MEd from The University of Texas MD Anderson Cancer Center speaks about Associations between the…
Santhosh Upadhyaya, MD, Pediatric Hematologist from St. Jude Children’s Research Hospital speaks about ATRT molecular groups: looking at the biology…
Lisa McKenzie, Founder, and Executive Producer, You Night Empowering Events speaks about being This Years Astellas Oncology C3 Prize -…
Douglas Johnson, MD, MSCI, associate professor of Medicine at Vanderbilt University Medical Center and clinical director of Melanoma at Vanderbilt-Ingram…
Jennifer C. King, Ph.D. CFO of the GO2 Foundation speaks about GO2 Foundation Leads Study to Improve Participation of Black…
Allison W. Kurian, MD, MSc from Stanford University California speaks about Genetic Testing for Breast and Ovarian Cancer: What Has…
Russell Langan, M.D., Chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center, an RWJBarnabas Health facility, and…
Veerle Groen, MD from the University Medical Center Utrecht, Radiation Oncology, Utrecht, the Netherlands speaks about Focal Boost to the…
An international team of researchers led by scientists from the University of California San Diego School of Medicine and Moores…
What is the C3 Prizeâ„¢? Â Cancer is a difficult disease to understand. Astellas Oncology acknowledges the complexity of the…
Prof. Giorgio Scagliotti Professor of Medical Oncology from the Università di Torino speaks about IASLC Statement on the Updated United…
Sherif Badawy, MD from Ann & Robert H. Lurie Children’s Hospital of Chicago speaks about A systematic review of quality…
Richard T. Lee, MD from Case Western Reserve University speaks about Familiarity With Complementary and Integrative Therapies Among Patients With…
Drs. Aggarwal & West welcome Drs. Jerad Gardner from Geisenger Medical Labs & Sanjay Mukhopadyay from Cleveland Clinic as they…
Xiaoqiang Wang, MD, Ph.D., MB (ASCP) from the City of Hope speaks about White button mushrooms could slow progression of…
Bradley McGregor, MD of the Dana-Farber Cancer Institute speaks about Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.Link to…
Lucas W. Thornblade, MD, MPH of the City of Hope speaks about Patterns of Whole Genome Sequencing and Actionable Mutations…
Jonathan Simons, MD, President, and CEO of the Prostate Cancer Foundation speaks about Study Training Dogs to Detect Prostate Cancer…
I think the field of cancer and in particular, head neck cancer has been. Somewhat revolutionized with the introduction of…
Amar Gajjar, MD from the Division of Neuro Oncology, Department of Oncology, St Jude Children’s Research Hospital discusses Outcomes by…
Christopher I. Amos, Ph.D. from the Dan L. Duncan Comprehensive Cancer Center, Department of Medicine, Baylor College of Medicine speaks…
Ethan Basch, MD, MSc from the Lineberger Comprehensive Cancer Center, University of North Carolina speaks about the Benefits of Digital…
Synopsis: Â The most common symptom of cancer and its treatments is fatigue. In patients with chronic fatigue syndrome and…
Jennifer Ribeiro, Ph.D. Assistant Professor of Obstetrics and Gynecology (Research) at Brown University and Women & Infants speaks about the…
Joel Neal, MD, Ph.D., Associate Professor Of Medicine (Oncology) from Stanford Cancer Institute/Stanford University speaks about Randomized Phase II Study…
According to new research published in the January 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network, more than…
Manish A. Shah, MD from Weill Cornell Medicine and New York-Presbyterian discuss the ASCO Pubs – Phase III Study to…
Flavio G. Rocha, MD, FACS, FSSO from the Division of Surgical Oncology, Knight Cancer Institute, Oregon Health and Science University,…
Drs. Aggarwal and West welcome Dr. Vincent Rajkumar, Professor of Medicine and multiple myeloma from Mayo Clinic, as they discuss…
Aditya Bardia, MD, MPH from Massachusetts General Hospital discusses SAR439859 Plus Palbociclib as First Line Therapy for Patients With ER(+)…
Professor Tony Hunter, Ph.D., and Rajasree Kalagiri, Ph.D. of the Salk Institute for Biological Studies discuss the article Salk team…
Tyler Seibert, MD, Ph.D. Principal Investigator and Assistant Professor at UC San Diego School of Medicine and radiation oncologist at…
Samuel R. Denmeade, MD of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins discusses TRANSFORMER: A Randomized Phase II…
Robert Zeiser, MD from the University Medical Center Freiburg, speaks about Incyte Announces Acceptance and Priority Review of sNDA for…
Johannes A. Schmid, Ph.D. from MedUni Vienna speaks about How inflammatory signaling molecules contribute to carcinogenesis.Link to Article -https://www.sciencedaily.com/releases/2021/02/210217114327.htmThe Whole…
Martin S. Tallman, MD from Weill Cornell and Sloan Kettering discusses Martin S. Tallman, MD, Begins Term as 2021 ASH…
Jason M. Link, Ph.D., Department of Molecular and Medical Genetics, Brenden-Colson Center for Pancreatic Care, Oregon Health and Science University…
Mehmet Asim Bilen, MD from Winship Cancer Institute of Emory University discusses the Evaluation of a novel blood pressure scoring…
Emerens Wensink, MD, Ph.D. Candidate from University Medical Center Utrecht, Utrecht University discusses Survival of patients with deficient mismatch repair…
MarÃa DÃez Campelo, MD of the Universidad de Salamanca speaks about a Randomized phase 2 trial of pevonedistat plus azacitidine…
Melissa L. Johnson, MD Director, Lung Cancer Research, Sarah Cannon Research Institute at Tennessee Oncology speaks about A phase 1 study…
Drs. Susan Love and Stephanie Graff join Drs. Aggarwal and West as they discuss the origins of the Love Foundation,…
Professor Thomas Powles, MD from Barts Cancer Centre, London, UK speaks about European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance…
Sheela Rao, MDS Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust discusses Incyte Announces Acceptance and Priority Review of…
Takeo Fujii, MD, MPH from MD Anderson Cancer Center speaks about the Incidence of immune-related adverse events and its association…
Roy S. Herbst, MD, Ph.D., chief of Medical Oncology at Yale University discusses the IASLC 2020 abstract – Lung-Map Translational…
Felix Y. Feng, MD, professor of radiation oncology, urology, and medicine from the University of California, San Francisco speaks about…
Jared Weiss, MD, Associate Professor Clinical Research Hematology/Oncology from Cancer Grace speaks about FDA Approves First Therapy Developed to Help…
Jonathan D. Tward, MD, Ph.D. from the Huntsman Cancer Institute and U Health – University of Utah speaks about New…
Anne L. Angiolillo, MD, MS, director of the Leukemia and Lymphoma Program at Children’s National Medical Center speaks about the…
Ashley E Ross, MD, Ph.D. From Northwestern University Feinberg School of Medicine speaks about Practical Applications of Novel Imaging and…
Zeynep Busra Zengin, MD, a postdoctoral fellow at the City of Hope, a comprehensive cancer center discusses the ASCO GU…
Cesar A. Santa-Maria, MD MSCI from Johns Hopkins speaks about the PRISMM Study – Patient Response to Immunotherapy Using Spliceosome…
Professor Thomas Powles, MD of Barts Cancer Centre, Queen Mary University of London speaks about Seattle Genetics and Astellas Announce…
Arjun Balar, MD from NYU Langone’s Perlmutter Cancer Center discusses Astellas and Seagen Announce Positive Topline Results from Second Cohort…
Yung Lyou, MD from the City of Hope speaks about High-throughput global transcriptional profiling to identify the STAT3 signaling pathway…
Kim Chi, MD, Vice President & Chief Medical Officer of BC Cancer speaks about TITAN: A final analysis with close…
Cathy Eng, MD, FACP, FASCO from Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center speaks about the Editorial – BRAF Mutation…
Prof. Michael Boyer of the Chris O’Brien Lifehouse and the University of Sydney discusses Pembrolizumab Plus Ipilimumab or Placebo for…
Sumanta (Monty) K. Pal, MD of the City of Hope speaks about A randomized, multi-arm comparison of targeted therapies for…
Pasi A. Jänne, MD, Ph.D. from Dana-Farber Cancer Institute discusses Takeda Presents New Data Highlighting Scientific Advancements in Lung Cancer…
Crystal Denlinger, MD of the Fox Chase Cancer Center discusses Crystal Denlinger Named Chief Scientific Officer for National Comprehensive Cancer…
Doreen M. Agnese, MD of The OSU Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute and/or Yale…
Enrique M. Ocio, MD, Ph.D. of the Marqués de Valdecilla University Hospital discusses ANCHOR (OP-104): Melflufen Plus Dexamethasone (dex) and…
Matthew Smith, MD, Professor of Medicine of Harvard Medical School and Director of the Genitourinary Malignancies Program at Massachusetts General…
Matthew Smith, MD, Professor of Medicine of Harvard Medical School and Director of the Genitourinary Malignancies Program at Massachusetts General…